Summit Therapeutics Inc (NAS:SMMT)
$ 18.21 -1.07 (-5.55%) Market Cap: 14.22 Bil Enterprise Value: 13.56 Bil PE Ratio: 0 PB Ratio: 32.46 GF Score: 29/100

Q3 2023 Summit Therapeutics Inc Earnings Call Transcript

Nov 07, 2023 / 02:00PM GMT
Release Date Price: $1.92 (-12.16%)
Operator

Good morning, and welcome to the Summit Therapeutics third quarter 2023 earnings and update call. (Operator Instructions) Please note that today's call is being recorded. At this time, I would like to introduce the call to Dave Gancarz, Chief Business and Strategy Officer. You may proceed.

Dave Gancarz
Summit Therapeutics Inc. - Chief Business and Strategy Officer

And thank you for joining us. Our press release was issued earlier this morning and is available on the homepage of our website. Our Form 10-Q was also filed earlier this morning and is available on our website. Today's call is being simultaneously webcast and an archived replay will be available later today on our website, www.smmttx.com.

Joining me on the call today is Bob Duggan, our Chairman of the Board and Chief Executive Officer; Dr. Maky Zanganeh, our Chief Executive Officer and President; Ankur Dhingra, our Chief Financial Officer; Dr. Allen Yang, our Chief Medical Officer. And in addition, we are joined by our new Chief

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot